When designing live-attenuated respiratory syncytial virus (RSV) vaccine candidates, attenuating mutations can be developed through biologic selection or reverse-genetic manipulation and may include point mutations, codon and gene deletions, and geno...
Journal of comparative effectiveness research
Sep 1, 2025
In this update, we examine Canada's Drug Agency position statement on artificial intelligence in evidence generation, a systematic review of clinical trial data linkage approaches, and real-world effectiveness evidence from England's respiratory sync...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.